1-4 of 4
Peter Damsbo
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

A Feasibility Study of a 3-Day Basal-Bolus Insulin Delivery Device in Individuals With Type 2 Diabetes

Julia K. Mader, Leslie C. Lilly, Felix Aberer, Stefan Korsatko, Ellie Strock, Roger S. Mazze, Peter Damsbo, Thomas R. Pieber
Journal: Diabetes Care
Diabetes Care 2014;37(5):1476–1479
https://doi.org/10.2337/dc13-2238
Published: 10 April 2014
View article titled, A Feasibility Study of a 3-Day Basal-Bolus Insulin Delivery Device in Individuals With Type 2 Diabetes
Open the PDF for A Feasibility Study of a 3-Day Basal-Bolus Insulin Delivery Device in Individuals With Type 2 Diabetes in another window
Journal Articles

Glucagon-Like Peptide-1 Infusion Must Be Maintained for 24 h/day to Obtain Acceptable Glycemia in Type 2 Diabetic Patients Who Are Poorly Controlled on Sulphonylurea Treatment

Jens Larsen, MD, Birgitte Hylleberg, MSC, Kevin Ng, MD, Peter Damsbo, MD
Journal: Diabetes Care
Diabetes Care 2001;24(8):1416–1421
https://doi.org/10.2337/diacare.24.8.1416
Published: 01 August 2001
View article titled, Glucagon-Like Peptide-1 Infusion Must Be Maintained for 24 h/day to Obtain Acceptable Glycemia in Type 2 Diabetic Patients Who Are Poorly Controlled on Sulphonylurea Treatment
Open the PDF for Glucagon-Like Peptide-1 Infusion Must Be Maintained for 24 h/day to Obtain Acceptable Glycemia in Type 2 Diabetic Patients Who Are Poorly Controlled on Sulphonylurea Treatment in another window
Journal Articles

Irreversibility of the Defect in Glycogen Synthase Activity in Skeletal Muscle From Obese Patients With NIDDM Treated With Diet and Metformin

Peter Damsbo, MD, Leif S Hermann, MD, PHD, Allan Vaag, MD, PHD, Ole Hother-Nielsen, MD, PHD, Henning Beck-Nielsen, MD, PHD
Journal: Diabetes Care
Diabetes Care 1998;21(9):1489–1494
https://doi.org/10.2337/diacare.21.9.1489
Published: 01 September 1998
View article titled, Irreversibility of the Defect in Glycogen Synthase Activity in Skeletal Muscle From Obese Patients With NIDDM Treated With Diet and Metformin
Open the PDF for Irreversibility of the Defect in Glycogen Synthase Activity in Skeletal Muscle From Obese Patients With NIDDM Treated With Diet and Metformin in another window
Journal Articles

Insulin Resistance in Skeletal Muscles in Patients With NIDDM

Henning Beck-Nielsen, PHD, Allan Vaag, MD, Peter Damsbo, MD, Aase Handberg, MD, Ole Hother Nielsen, MD, Jan Erik Henriksen, MD, Peter Thye-Rønn, MD
Journal: Diabetes Care
Diabetes Care 1992;15(3):418–429
https://doi.org/10.2337/diacare.15.3.418
Published: 01 March 1992
View article titled, Insulin Resistance in Skeletal Muscles in Patients With NIDDM
Open the PDF for Insulin Resistance in Skeletal Muscles in Patients With NIDDM in another window